Park Square has placed David Raben, M.D., as Chief Medical Officer at Pliant Therapeutics
| less than a minute read
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
Get in touch
Get in touch
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today announced the appointment of David Raben, M.D., as Chief Medical Officer.
Get in touch
Get in touch
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-29-16-59-13-899-6abbee61460fb9469a25b973.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-10-21-12-53-31-969-6ad8b5cb057433a11d528afb.jpg)
/Passle/58a5cb8db00e8110e83aa395/SearchServiceImages/2026-10-19-20-59-27-876-6ad684af780cfbe7accbf179.jpg)
